PURPLE BIOTECH LTD's ticker is PPBT and the CUSIP is 74638P109. A total of 19 filers reported holding PURPLE BIOTECH LTD in Q3 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,000 | – | 375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 50,590 | $247,000 | 0.04% |
| Point72 Asset Management, L.P. | 525,000 | $2,562,000 | 0.01% |
| Belvedere Trading LLC | 31,000 | $150,000 | 0.01% |
| CONDOR CAPITAL MANAGEMENT | 21,000 | $102,000 | 0.01% |
| WASHINGTON TRUST BANK | 16,454 | $80,000 | 0.01% |
| Belvedere Trading LLC | 5,600 | $27,000 | 0.00% |
| Orbimed Advisors | 17,712 | $86,000 | 0.00% |
| HAP Trading, LLC | 20,600 | $21,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 42,281 | $206,000 | 0.00% |